AR067929A1 - Composicion terapeutica saborizada basada en arcilla - Google Patents
Composicion terapeutica saborizada basada en arcillaInfo
- Publication number
- AR067929A1 AR067929A1 ARP080103533A ARP080103533A AR067929A1 AR 067929 A1 AR067929 A1 AR 067929A1 AR P080103533 A ARP080103533 A AR P080103533A AR P080103533 A ARP080103533 A AR P080103533A AR 067929 A1 AR067929 A1 AR 067929A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition according
- therapeutic composition
- smectite
- arcilla
- composition based
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 229910021647 smectite Inorganic materials 0.000 abstract 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 2
- 229920002774 Maltodextrin Polymers 0.000 abstract 2
- 239000005913 Maltodextrin Substances 0.000 abstract 2
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 abstract 2
- 239000004927 clay Substances 0.000 abstract 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 abstract 2
- 229960002737 fructose Drugs 0.000 abstract 2
- 229940035034 maltodextrin Drugs 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 229910052901 montmorillonite Inorganic materials 0.000 abstract 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 abstract 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- 239000005715 Fructose Substances 0.000 abstract 1
- 229930091371 Fructose Natural products 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000000905 isomalt Substances 0.000 abstract 1
- 235000010439 isomalt Nutrition 0.000 abstract 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000832 lactitol Substances 0.000 abstract 1
- 235000010448 lactitol Nutrition 0.000 abstract 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 abstract 1
- 229960003451 lactitol Drugs 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000845 maltitol Substances 0.000 abstract 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 abstract 1
- 235000010449 maltitol Nutrition 0.000 abstract 1
- 229940035436 maltitol Drugs 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 229960001855 mannitol Drugs 0.000 abstract 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 229960002920 sorbitol Drugs 0.000 abstract 1
- 235000010356 sorbitol Nutrition 0.000 abstract 1
- 239000005720 sucrose Substances 0.000 abstract 1
- 239000000811 xylitol Substances 0.000 abstract 1
- 235000010447 xylitol Nutrition 0.000 abstract 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract 1
- 229960002675 xylitol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
- Cosmetics (AREA)
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Composicion terapéutica saborizada que contiene una arcilla como principio activo, y caracterizada porque la arcilla es una esmectita dioctaédrica y el sabor está encapsulado. Reivindicacion 2: Composicion de acuerdo con la reivindicacion 1, caracterizada porque la esmectita dioctaédrica es una montmorillonita o una beidellita o una estructura cristalográfica intermedia entre los dos extremos cristaloquímicos: montmorillonita y beidellita. Reivindicacion 5: Composicion de acuerdo con alguna de las reivindicaciones precedentes, caracterizada porque la esmectita dioctaédrica es la esmectita conocida como ôdiosmectitaö. Reivindicacion 17: Composicion de acuerdo con alguna de las reivindicaciones precedentes, caracterizada porque el sabor esta encapsulado en una matriz vítrea de carbohidratos. Reivindicacion 18: Composicion de acuerdo con la reivindicacion precedente, caracterizada porque la matriz está constituida por maltodextrina o una mezcla de maltodextrina y al menos un producto elegido entre: sacarosa, glucosa, lactosa, levulosa, maltosa, fructosa, isomalt, sorbitol, manitol, xilitol, lactitol, maltitol e hidrolizados de almidon hidrogenado.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07291005A EP2025332A1 (fr) | 2007-08-13 | 2007-08-13 | Composition thérapeutique aromatisée à base d'argile |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR067929A1 true AR067929A1 (es) | 2009-10-28 |
Family
ID=39052728
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080103533A AR067929A1 (es) | 2007-08-13 | 2008-08-13 | Composicion terapeutica saborizada basada en arcilla |
| ARP180103440A AR114148A2 (es) | 2007-08-13 | 2018-11-23 | Composición terapéutica saborizada basada en arcilla |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180103440A AR114148A2 (es) | 2007-08-13 | 2018-11-23 | Composición terapéutica saborizada basada en arcilla |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US20100159013A1 (es) |
| EP (3) | EP2025332A1 (es) |
| JP (2) | JP5670189B2 (es) |
| KR (2) | KR20140133617A (es) |
| CN (2) | CN104173371A (es) |
| AR (2) | AR067929A1 (es) |
| BR (1) | BRPI0814979A2 (es) |
| CA (1) | CA2696062C (es) |
| CL (1) | CL2008002366A1 (es) |
| DK (1) | DK2194968T3 (es) |
| EA (1) | EA017118B1 (es) |
| ES (2) | ES2582871T3 (es) |
| GE (1) | GEP20125539B (es) |
| HU (1) | HUE029713T2 (es) |
| MA (1) | MA31678B1 (es) |
| ME (1) | ME00975B (es) |
| MX (1) | MX2010001533A (es) |
| NO (1) | NO20100114L (es) |
| PE (1) | PE20090939A1 (es) |
| PL (2) | PL2194968T3 (es) |
| PT (2) | PT2194968E (es) |
| SA (1) | SA08290496B1 (es) |
| TN (1) | TN2010000058A1 (es) |
| TW (2) | TWI519303B (es) |
| UA (1) | UA97408C2 (es) |
| WO (1) | WO2009056703A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2025332A1 (fr) * | 2007-08-13 | 2009-02-18 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Composition thérapeutique aromatisée à base d'argile |
| FR2952814B1 (fr) * | 2009-11-23 | 2013-07-19 | Ephyla Sas | Composition comprenant un complexe de phyllosilicates organiquement modifies generer des emulsions huile dans eau eventuellement a froid |
| ES2590127T3 (es) | 2011-01-12 | 2016-11-18 | Sooft Italia S.P.A. | Administración corneal de agentes de entrecruzamiento por iontoforesis para el tratamiento de queratocono y composiciones oftálmicas relacionadas |
| ITUA20162277A1 (it) * | 2016-04-04 | 2017-10-04 | Chemists Res Srl | Composizione comprendente diosmectite |
| CN105902625A (zh) * | 2016-05-26 | 2016-08-31 | 朱胜利 | 一种小儿止泻药的服用方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986000502A1 (en) | 1984-07-16 | 1986-01-30 | Sunkist Growers, Inc. | Solid essential oil flavor composition and method of manufacture |
| US4707367A (en) | 1984-07-16 | 1987-11-17 | Sunkist Growers, Inc. | Solid essential oil flavor composition |
| JPH064530B2 (ja) * | 1985-02-23 | 1994-01-19 | 日本化薬株式会社 | 親水性基剤 |
| US5288497A (en) * | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
| AU6701694A (en) * | 1993-04-16 | 1994-11-08 | Mccormick & Company, Inc. | Encapsulation compositions |
| FR2770778B1 (fr) * | 1997-11-12 | 2000-05-26 | Investigations Therapeutiques | Composition pour le traitement des gastro-enterites aigues, procede de fabrication de cette composition et solution de traitement obtenue a partir de cette composition |
| KR20030050958A (ko) * | 2001-12-20 | 2003-06-25 | 송우영 | 디옥타헤드랄 스멕타이트를 유효성분으로 함유하는 항균성외용조성물 |
| US8334007B2 (en) * | 2003-03-19 | 2012-12-18 | Firmenich Sa | Continuous process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix |
| CN100340235C (zh) * | 2004-05-21 | 2007-10-03 | 山东绿叶制药有限公司 | 蒙脱石分散片及其制备工艺 |
| EP1627573A1 (en) * | 2004-08-20 | 2006-02-22 | Firmenich Sa | A process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix |
| JP2006083071A (ja) * | 2004-09-14 | 2006-03-30 | Takasago Internatl Corp | 香粧品用固形製剤 |
| WO2007051427A1 (en) * | 2005-11-04 | 2007-05-10 | Zhejiang Hailisheng Pharmaceutical Limited Co. | Modified montmorillonite, method for preparing the same and use thereof |
| FR2901360A1 (fr) | 2006-05-16 | 2007-11-23 | Horiba Abx Sas Soc Par Actions | Dispositif de conditionnement pour analyse biologique |
| EP2025332A1 (fr) * | 2007-08-13 | 2009-02-18 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Composition thérapeutique aromatisée à base d'argile |
-
2007
- 2007-08-13 EP EP07291005A patent/EP2025332A1/fr not_active Withdrawn
-
2008
- 2008-07-23 TW TW097127881A patent/TWI519303B/zh active
- 2008-07-23 TW TW103138915A patent/TWI511734B/zh active
- 2008-08-10 SA SA08290496A patent/SA08290496B1/ar unknown
- 2008-08-11 PE PE2008001364A patent/PE20090939A1/es active IP Right Grant
- 2008-08-12 EA EA201070257A patent/EA017118B1/ru unknown
- 2008-08-12 PL PL08843692T patent/PL2194968T3/pl unknown
- 2008-08-12 EP EP13002485.4A patent/EP2710998B1/fr not_active Not-in-force
- 2008-08-12 EP EP08843692.8A patent/EP2194968B1/fr active Active
- 2008-08-12 KR KR1020147030942A patent/KR20140133617A/ko not_active Ceased
- 2008-08-12 CA CA2696062A patent/CA2696062C/fr not_active Expired - Fee Related
- 2008-08-12 PT PT88436928T patent/PT2194968E/pt unknown
- 2008-08-12 JP JP2010520608A patent/JP5670189B2/ja not_active Expired - Fee Related
- 2008-08-12 PT PT130024854T patent/PT2710998T/pt unknown
- 2008-08-12 DK DK08843692.8T patent/DK2194968T3/da active
- 2008-08-12 PL PL13002485.4T patent/PL2710998T3/pl unknown
- 2008-08-12 BR BRPI0814979-8A2A patent/BRPI0814979A2/pt not_active Application Discontinuation
- 2008-08-12 MX MX2010001533A patent/MX2010001533A/es active IP Right Grant
- 2008-08-12 HU HUE13002485A patent/HUE029713T2/en unknown
- 2008-08-12 US US12/733,172 patent/US20100159013A1/en not_active Abandoned
- 2008-08-12 ES ES13002485.4T patent/ES2582871T3/es active Active
- 2008-08-12 UA UAA201002684A patent/UA97408C2/ru unknown
- 2008-08-12 ME MEP-2010-20A patent/ME00975B/me unknown
- 2008-08-12 CN CN201410349941.6A patent/CN104173371A/zh active Pending
- 2008-08-12 KR KR1020107005450A patent/KR101503957B1/ko active Active
- 2008-08-12 CL CL2008002366A patent/CL2008002366A1/es unknown
- 2008-08-12 ES ES08843692T patent/ES2421379T3/es active Active
- 2008-08-12 CN CN200880103357A patent/CN101778622A/zh active Pending
- 2008-08-12 WO PCT/FR2008/001185 patent/WO2009056703A1/fr not_active Ceased
- 2008-08-12 GE GEAP200811722A patent/GEP20125539B/en unknown
- 2008-08-13 AR ARP080103533A patent/AR067929A1/es not_active Application Discontinuation
-
2010
- 2010-01-22 NO NO20100114A patent/NO20100114L/no not_active Application Discontinuation
- 2010-02-05 TN TNP2010000058A patent/TN2010000058A1/fr unknown
- 2010-02-05 MA MA32592A patent/MA31678B1/fr unknown
-
2014
- 2014-02-12 US US14/178,445 patent/US9056055B2/en not_active Expired - Fee Related
- 2014-08-13 JP JP2014164964A patent/JP2014208715A/ja active Pending
-
2018
- 2018-11-23 AR ARP180103440A patent/AR114148A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2565464T3 (es) | Pastilla medicamentosa con liberación lenta del principio activo | |
| AR067929A1 (es) | Composicion terapeutica saborizada basada en arcilla | |
| RU2012140015A (ru) | Новые композиции подсластителей | |
| AR048705A1 (es) | Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii | |
| AR109170A2 (es) | Esfingomielinasa ácida para uso en la prevención o el tratamiento de la enfermedad de niemann-pick a o b en un paciente | |
| AR069128A1 (es) | Forma de dosificacion que se desintegra oralmente y proceso de preparacion | |
| AR051048A1 (es) | Sustituto del azucar bajo en calorias o sin calorias, no higroscopico | |
| MX2010003550A (es) | Forma de dosificacion intraoral con multiples porciones con propiedades organolepticas. | |
| AR055631A1 (es) | Composicion farmaceutica estable de glimepirida con liberacion inmediata y metformina con liberacion prolongada | |
| CL2012001251A1 (es) | Composicion de confiteria helada reducida en azucar y libre de edulcorante intenso y poliol, con menos de 15% p/p de azucar total, al menos 1% de sacarosa, donde la cantidad de fructosa es de hasta 75% de los azucares agregados, mas de 8% de solidos de leche no grasos, menos de 7% de oligo- y/o polisacaridos (div. 1101-08). | |
| AR056180A1 (es) | Composiciones de edulcorante sintetico con perfil de sabor y/ o perfil temporal mejorado, metodos para su formulacion y usos | |
| AR057918A1 (es) | Composicion farmaceutica con edulcorante de alta potencia | |
| AR083679A1 (es) | Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos | |
| ECSP089010A (es) | Composiciones farmacéuticas estabilizadas que comprenden fesoterodina | |
| BRPI0412589A (pt) | misturas com um perfil de sabor e doçura de xarope de milho com elevado teor de frutose hfcs 55 compreendendo hfcs 42 e acessulfame k | |
| AR040036A1 (es) | Tratamiento de la mucositis | |
| RU2010141595A (ru) | Композиция жевательной резинки (варианты) и ее наполнитель | |
| AR073365A1 (es) | Preparacion farmaceutica solida de liberacion sostenida | |
| BR112019009982A2 (pt) | método e composição para formulações brutas de açúcar fortificado para controle glicêmico | |
| WO2006120574A3 (en) | Analogs of 4-hydroxyisoleucine and uses thereof | |
| JP2007504194A5 (es) | ||
| HRP20160269T1 (hr) | Pripravak za topijsko liječenje | |
| PE20051156A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| WO2006117696A3 (en) | Diastereoisomers of 4-hydroxyisoleucine and uses thereof | |
| JP2015537019A5 (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FC | Refusal |